INMD
InMode Ltd.
NASDAQ · Healthcare · Medical - Devices · IL
$14.91
+0.47%Year over year
Reported trailing growth
- Revenue
- -6.7%
- EBITDA
- -35.4%
- EBIT
- -39.6%
- EPS
- -49.8%
- Free cash flow
- -16.1%
- Operating cash flow
- -15.5%
Forward estimates
Based on analyst estimates
- Revenue
- -0.6%
- EBITDA
- +3.3%
- EPS
- +5.6%
Three-year CAGR
- Revenue
- -6.6%
- EBITDA
- -18.1%
- EBIT
- -24.4%
- Net income
- -16.6%
- EPS
- -9.6%
- Free cash flow
- -22.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026